Every article on this site is written by AI from official sources and checked by a second AI. How it works

GAO recommends three fixes to FDA technology plan

Part of our Federal Regulation coverage: background and related stories

The U.S. Government Accountability Office on Wednesday said the Food and Drug Administration should more fully document how it tracks technology challenges and how major investments support its goals.

FDA relies heavily on information technology, or IT, to help protect public health and the safety of medical products, according to the report. The agency is funding 17 major IT investments and has developed a strategic plan to guide that work.

Open GAO recommendations to FDA
RecommendationStatus
Track progress on key IT modernization challengesOpen
Link major IT investments to plan goals and identify high-level expendituresOpen
Document use of performance metrics for the CDRH Digital Transformation investmentOpen
Source: U.S. Government Accountability Office.

The plan addresses important practices used in strategic planning, GAO said. It identifies goals and measures that line up with the agency’s mission. A set of planning documents fully meets six of eight leading practices, the report said.

Those documents align with agency and department missions, set measures for meeting IT goals, and define roles and responsibilities, according to GAO. The documents also capture key agencywide modernization efforts still ahead.

Two practices were not fully met. FDA has not fully documented how it will monitor efforts to reduce key obstacles to its IT goals, GAO found. It also has not identified links between its major IT investments and those goals.

GAO said adding those details would let FDA anticipate and overcome key challenges and carry out major investments in line with its goals.

GAO reviewed the five largest major IT investments. For those projects, FDA fully met two of three leading practices for measuring performance and partly met one, the report said. The agency created measures for each investment that matched its IT goals and used them to track results. It did not show that it used those measures to manage and improve results for one of the five.

GAO made three recommendations, all still open. It said the FDA commissioner should require the acting head of the Office of Mission IT Services to add a plan to directly track progress against the key modernization challenges described in the strategic plan. The commissioner should also have that official explain how each ongoing major investment relates to the plan’s goals, priorities and projects, and identify high-level spending for projects listed in the plan.

A third recommendation calls for documenting use of performance measures in managing the Center for Devices and Radiological Health Digital Transformation investment. The Department of Health and Human Services agreed with the three recommendations and outlined planned steps to carry them out, the report said. GAO said it will update its findings after it confirms what the agency has done.

A 2023 consolidated spending law called for FDA to develop an updated IT strategic plan and directed GAO to assess that plan and the agency’s IT investments. GAO said it had earlier reported shortfalls in FDA’s ability to produce an IT plan that was comprehensive and aligned with agency goals.

  1. Strategic Plan: FDA Could Further Strengthen Robust IT Modernization Plan — U.S. Government Accountability Office
How this article was made
Written with
Grok 4.7 (xAI)
Fact-checked by
Claude Sonnet 5.5 (Anthropic) — passed after revision
Generated
Nov. 19, 2026, 7:44 a.m. ET
Sources used
1 official source, listed above
Article type
Standard

The AI wrote only from the sources listed. No human reporter was involved. Read our standards or compare the models in the AI Report Card.